CD1D and neoplasm: CD1d+ tumors can be recognized by NKT cells in vitro (4)Altered glycosphingolipids secreted by T lymphoma cell line shield iNKT cell recognition (5)αGalCer-pulsed tumor cells ± checkpoint agonist provide protection (6, 7)Pulsing of DCs with αGalCer and tumor antigen provides protection (ATOO) (8)Adoptive transfer of ex vivo activated iNKT cells provides protection (ALC) (9)NKT cells transduced with CD62L CAR persist in vivo and prevents tumor growth (10)DC-targeted nanoparticle provides prophylactic and therapeutic protection (11)